<ref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="B20"><label>20</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bathgate</surname><given-names>RAD</given-names></name><name><surname>Kocan</surname><given-names>M</given-names></name><name><surname>Scott</surname><given-names>DJ</given-names></name><name><surname>Hossain</surname><given-names>MA</given-names></name><name><surname>Good</surname><given-names>SV</given-names></name><name><surname>Yegorov</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>The relaxin receptor as a therapeutic target - perspectives from evolution and drug targeting</article-title>. <source>Pharmacol Ther</source> (<year>2018</year>) <volume>187</volume>:<page-range>114&#8211;32</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.pharmthera.2018.02.008</pub-id>
</mixed-citation></ref>